Diabetes

Hepatic glucagon receptor signaling enhances insulin-stimulated glucose disposal in rodents.  67:2157-2166. 2018

Glucagon receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21.  67:1773-1782. 2018

Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice.  67:1867-1879. 2018

Genome-wide association study of serum fructosamine and glycated albumin in adults without diagnosed diabetes: Results from the atherosclerosis risk in communities study.  67:1684-1696. 2018

miR-204 controls glucagon-like peptide 1 receptor expression and agonist function.  67:256-264. 2018

Hepatic but not extrahepatic insulin clearance is lower in African American than in European American women.  66:2564-2570. 2017

Genetics of type 2 diabetes in U.S. Hispanic/Latino individuals: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).  66:1419-1425. 2017

Gestational diabetes mellitus from inactivation of prolactin receptor and MafB in islet β-cells.  65:2331-2341. 2016

Skeletal muscle TRIB3 mediates glucose toxicity in diabetes and high-fat diet-induced insulin resistance.  65:2380-2391. 2016

Loss of NOX-derived superoxide exacerbates diabetogenic CD4 T-cell effector responses in type 1 diabetes.  64:4171-4183. 2015

Augmented STAT5 signaling bypasses multiple impediments to lactogen-mediated proliferation in human β-cells.  64:3784-3797. 2015

β-cell microRNAs: Small but powerful.  64:3631-3644. 2015

Unsticking the broken diabetic heart: O-GlcNAcylation and calcium sensitivity.  64:3339-3341. 2015

Growth hormone inhibits hepatic de novo lipogenesis in adult mice.  64:3093-3103. 2015

Response to Comment on Sofi et al. pH of drinking water influences the composition of gut microbiome and type 1 diabetes incidence. Diabetes 2014;63:632-644.  64:e20-e21. 2015

Loss of NADPH oxidase-derived superoxide skews macrophage phenotypes to delay type 1 diabetes.  64:937-946. 2015

Inhibition of Ca²⁺-independent phospholipase A2β (iPLA2β) ameliorates islet infiltration and incidence of diabetes in NOD mice.  64:541-554. 2015

A31: Rare and Common Exome Variants Are Associated with Fasting Glucose and Insulin Levels-The CHARGE-S Exome Chip and Sequencing Study.  63:A37-A37. 2014

BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans.  63:791-800. 2014

Epigenome-wide association study of fasting measures of glucose, insulin, and homa-ir in the genetics of lipid lowering drugs and diet network study.  63:801-807. 2014

GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats.  63:505-513. 2014

Bilirubin: A potential biomarker and therapeutic target for diabetic nephropathy.  63:2613-2616. 2014

Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors.  63:122-131. 2014

Downregulation of carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion.  63:3805-3814. 2014

Effect of guanylate cyclase-C activity on energy and glucose homeostasis.  63:3798-3804. 2014

Islet-1 is essential for pancreatic β-cell function.  63:4206-4217. 2014

KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression.  63:2949-2961. 2014

TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway.  62:4192-4200. 2013

GLP-1R agonism enhances adjustable gastric banding in diet-induced obese rats.  62:3261-3267. 2013

A431: Epigenetics of Fasting Insulin and Glucose Concentrations.  62:A431-A431. 2013

Fibroblast growth factor 21 mediates specific glucagon actions.  62:1453-1463. 2013

Islet a-, b-, and d-Cell development is controlled by the ldb1 coregulator, acting primarily with the islet-1 transcription factor.  62:875-886. 2013

Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow.  62:273-282. 2013

Clinical islet xenotransplantation: How close are we?.  61:3046-3055. 2012

Caloric restriction chronically impairs metabolic programming in mice.  61:2734-2742. 2012

Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance.  61:2776-2786. 2012

Preventing β-cell loss and diabetes with calcium channel blockers.  61:848-856. 2012

IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response.  60:3223-3234. 2011

Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.  60:2624-2634. 2011

Superoxide production by macrophages and T cells is critical for the induction of autoreactivity and type 1 diabetes.  60:2144-2151. 2011

Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance.  60:177-188. 2011

Redox modulation protects islets from transplant-related injury.  59:1731-1738. 2010

Admixture Mapping of Type 2 Diabetes and Lipoprotein Subclasses in Gullah-Speaking African Americans in Project SuGAR.  59:A337-A337. 2010

Changes in Insulin Sensitivity in Overweight/Obese Patients Treated with Low-Dose, Controlled-Release Phentermine/Topiramate(PHEN/TPM).  59:A481-A481. 2010

Diabetes and Oral Health among Rural, Ethnically Diverse Older Adults.  59:A307-A307. 2010

Effects of Resistance Exercise and Aging on NR4A Protein Levels in Skeletal Muscle.  59:A319-A320. 2010

Enhanced Rat Islet Function and Survival In Vitro Using a Biomimetic Self-Assembled Nanomatrix Gel.  59:A533-A533. 2010

Improvements in Dyslipidemia and Other Cardiometabolic Disease Risk Factors with Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM).  59:A290-A291. 2010

Initial Combination Therapy with Metformin plus Colesevelam Safely Achieves Glycemic and Lipid Goals with Less Diarrhea in Early Type 2 Diabetes Mellitus.  59:A187-A187. 2010

Lipid Metabolism Modulated by Macrophage Adiponectin Expression In Vivo.  59:A433-A433. 2010

Macrophage and T Cell ROS Production Is Critical for T1D Pathogenesis.  59:A361-A361. 2010

Metabolic Effects of Adipocyte-Specific NR4A3 Over-Expression in Mice.  59:A394-A394. 2010

Osteocalcin Effects on Cytokine Secretion by Adipose Tissue and Glucose Uptake in L6 Muscle Cells: Linking the Skeleton with Insulin Resistance and Inflammation.  59:A395-A395. 2010

The Safety and Tolerability of Metformin plus Colesevelam in Drug-Naive Patients with Early Type 2 Diabetes Mellitus.  59:A173-A173. 2010

Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis.  59:791-799. 2010

Duration of lactation and incidence of the metabolic syndrome in women of reproductive age according to gestational diabetes mellitus status: A 20-year prospective study in CARDIA (Coronary Artery Risk Development in Young Adults).  59:495-504. 2010

Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated β-cell death.  59:440-447. 2010

HDL as a biomarker, potential therapeutic target, and therapy.  58:2711-2717. 2009

Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance.  58:2498-2505. 2009

FoxO1 links insulin resistance to proinflammatory cytokine IL-1β production in macrophages.  58:2624-2633. 2009

Selective inhibition of protein kinase C β2 attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.  58:2355-2364. 2009

Islet-1 is required for the maturation, proliferation, and survival of the endocrine pancreas.  58:2059-2069. 2009

Apolipoprotein-Defined Lipoproteins in the DCCT/EDIC Cohort: Associations with Diabetic Nephropathy in Type 1 Diabetes.  58:A243-A243. 2009

Genes and Biochemical Pathways in Human Skeletal Muscle Affecting Resting Energy Expenditure and Fuel Partitioning.  58:A362-A362. 2009

Inhibition of Superoxide Synthesis Prevents T Cell Autoreactivity.  58:A50-A50. 2009

One-Year Treatment with VI-0521 in Type 2 Diabetes Demonstrates Continued Glycemic Improvement and Weight Loss.  58:A95-A95. 2009

Redox Modulation Ablates Adaptive Immune Effector Response by Inhibiting IL-12-IL-12R Signaling.  58:A327-A328. 2009

Genome-wide linkage scan in gullah-speaking african american families with type 2 diabetes: The sea islands genetic African American Registry (Project SuGAR).  58:260-267. 2009

Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: Evidence for blunted responsiveness in diabetes.  57:2488-2494. 2008

Effect of VI-0521 (phentermine and topiramate) in type 2 diabetes.  57:A112-A112. 2008

Genome-wide linkage scan in Gullah-speaking African American families with Type 2 diabetes: The Sea Islands Genetic African American Registry (Project SuGAR).  57:A321-A321. 2008

Metabolic syndrome traits and endothelial dysfunction: Role of ethnicity.  57:A620-A620. 2008

Osteocalcin is not just for bones: Effects on adipocytes and role in human metabolism.  57:A29-A29. 2008

Overexpression of adiponectin reduces lipid accumulation in human THP-1 macrophage foam cells.  57:A631-A631. 2008

Reactive oxygen species generation is necessary for diabetogenic T cell effector function.  57:A354-A354. 2008

Redox modulation impairs allograft rejection.  57:A543-A544. 2008

Redox modulation regulates T cell activation and effector function through a tumor necrosis factor alpha converting enzyme (TACE) dependent mechanism.  57:A53-A53. 2008

The HOMA index estimation of insulin resistance is affected by ethnicity.  57:A292-A292. 2008

Thioredoxin-interacting protein A critical link between glucose toxicity and β-cell apoptosis.  57:938-944. 2008

A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: The coronary artery risk development in young adults (CARDIA) study.  56:2990-2996. 2007

Body size and shape changes and the risk of diabetes in the diabetes prevention program.  56:1680-1685. 2007

Critical role of superoxide (O2-) production in the pathogenesis of autoimmune diabetes (T1D).  56:A59-A59. 2007

Ethnic differences in adiponectin multimer distribution and relationships with metabolic syndrome traits.  56:A361-A361. 2007

Fat depots and adipokines in morbidly obese individuals.  56:A464-A464. 2007

Functional study of Trb 3 related to diabetic skeletal muscle.  56:A346-A346. 2007

Pioglitazone therapy restores the coupling of electron transport to ATP synthesis in skeletal muscle of obese zucker rats.  56:A85-A86. 2007

Reactive oxygen species generation is necessary for autoimmune T cell effector function.  56:A58-A59. 2007

Genotype-by-sex interaction on fasting insulin concentration: The HyperGEN study.  56:137-142. 2007

Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility.  55:3455-3462. 2006

Polymorphism in the transcription factor 7-Like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women.  55:3630-3634. 2006

Suppressed insulin signaling and increased apoptosis in Cd38-null islets.  55:2737-2746. 2006

A diabetes management program using diabetes-specific meal replacements and snack bars improves weight loss, metabolic parameters, and quality of life (QOL).  55:A596-A596. 2006

A role for C/EBP-delta in mitochondrial dysfunction and insulin resistance in skeletal muscle.  55:A304-A304. 2006

Blockade of the inflammatory third signal in conjunction with antigenic immunization as a potentially novel immunosuppression strategy.  55:A447-A447. 2006

CETP gene variation has pronounced independent effect on HDL levels and HDL particle size in type 1 diabetes.  55:A252-A252. 2006

Effects of short-term very low calorie diet (VLCD) on secretion of adipocytokines in human adipose tissue.  55:A313-A313. 2006

Redox modulation inhibits diabetogenic T cell activation and T1D.  55:A89-A89. 2006

Resistin autoregulates inflammatory cytokine production and induces insulin resistance in adipocytes.  55:A310-A310. 2006

The role of ER-stress in the antigenic response of the BDC-2.5 T cell.  55:A88-A88. 2006

Quantitative trait loci on chromosome 8q24 for pancreatic β-cell function and 7q11 for insulin sensitivity in obese nondiabetic white and black families: Evidence from genome-wide linkage scans in the NHLBI Hypertension Genetic Epidemiology Network (HyperGEN) study.  55:551-558. 2006

Adiponectin multimeric complexes and the metabolic syndrome trait cluster.  55:249-259. 2006

Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents.  54:2772-2778. 2005

Adiponectin multimeric complexes and the metabolic syndrome trait cluster.  54:A347-A348. 2005

Administration of pioglitazone to LDL receptor-deficient mice inhibits progression of intimal lesions and expression of matrix metalloproteinases and adhesion molecules.  54:A182-A182. 2005

Catalytic antioxidant disruption of innate-mediated pro-inflammatory cytokine and reactive oxygen species third signal delays spontaneous autoimmune diabetes in the NOD mouse.  54:A25-A25. 2005

Dysregulation of mitochondria-related genes in skeletal muscle from insulin resistant humans is associated with suppression of transcription factors involved in mitochondrial biogenesis.  54:A273-A273. 2005

Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages.  54:A188-A188. 2005

Proteomics analysis of skeletal muscle mitochondria in type 2 diabetes reveals altered concentrations and oxidation of respiratory chain proteins.  54:A58-A59. 2005

Linkage analysis of diabetes status among hypertensive families: The hypertension genetc epidemiology network study.  53:3307-3312. 2004

Activated protein C preserves functional islet mass after intraportal transplantation: A novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death.  53:2804-2814. 2004

Impaired Cardiac Efficiency and Increased Fatty Acid Oxidation in Insulin-Resistant ob/ob Mouse Hearts.  53:2366-2374. 2004

Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting.  53:1671-1679. 2004

Associations of adiponectin with retinopathy in the DCCT/EDIC cohort: Influence of insulin resistance.  53:A254-A254. 2004

Disruption of pro-inflammatory cytokine and reactive oxygen species dependent third signal leads to antigen-specific hyporesponsiveness that is STAT-4 dependent.  53:A301-A302. 2004

Effects of atypical antipsychotic drugs on insulin action in adipocytes.  53:A150-A150. 2004

Genetic ablation of macrophage/neutrophil NADPH oxidase activity inhibits T1D development in NOD mice.  53:A26-A26. 2004

Overexpression of adiponectin but not resistin enhances adipocyte differentiation and insulin sensitivity.  53:A79-A79. 2004

Quelling oxidative stress during human islet isolation correlates with reduced NF-kappa B-dependent pro-inflammatory mediators: Implications for the development of footprint assays for transplant success.  53:A454-A454. 2004

Hexosamine Pathway Is Responsible for Inhibition by Diabetes of Phenylephrine-Induced Inotropy.  53:1074-1081. 2004

Beta-cell calcium-independent group VIA phospholipase A(2) (iPLA(2)beta): tracking iPLA(2)beta movements in response to stimulation with insulin secretagogues in INS-1 cells..  53 Suppl 1:S186-S189. 2004

Islet Complex Lipids: Involvement in the Actions of Group VIA Calcium-Independent Phospholipase A2 in β-Cells.  53. 2004

Caspase-1 Is Not Required for Type 1 Diabetes in the NOD Mouse.  53:99-104. 2004

Activation of Vascular Endothelial Growth Factor Receptor-1 Sustains Angiogenesis and Bcl-2 Expression Via the Phosphatidylinositol 3-Kinase Pathway in Endothelial Cells.  52:2959-2968. 2003

Brain Death Significantly Reduces Isolated Pancreatic Islet Yields and Functionality In Vitro and In Vivo after Transplantation in Rats.  52:2935-2942. 2003

Linkage Analysis of a Composite Factor for the Multiple Metabolic Syndrome: The National Heart, Lung, and Blood Institute Family Heart Study.  52:2840-2847. 2003

Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-β activity.  52:2144-2150. 2003

Alterations in skeletal muscle caveolins 1 and 3 in human insulin resistance and obesity.  52:A330-A331. 2003

Relationship between insulin senstivity and intramyocellular lipid during short term very low calorie diet in obese type 2 diabetics.  52:A328-A328. 2003

Plasma prekallikrein: A risk marker for hypertension and nephropathy in type 1 diabetes.  52:1215-1221. 2003

Using genetic admixture to explain racial differences in insulin-related phenotypes.  52:1047-1051. 2003

Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.  52:708-716. 2003

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.  52:453-462. 2003

Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes.  51:3461-3467. 2002

Troglitazone antagonizes metabolic effects of glucocorticoids in humans: Effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.  51:2895-2902. 2002

Flotillin-1 expression in skeletal muscle is altered in insulin resistant humans.  51:A302-A302. 2002

Hepatic lipase gene polymorphism is a major determinant of HDL level and HDL size in men with type 1 diabetes in the DCCT/EDIC.  51:A20-A20. 2002

Therapeutic induction of diabetes resistance and antigen-specific hyporesponsiveness using a superoxide dismutase mimic (AEOL 10113).  51:A288-A289. 2002

Type 2 diabetes leads to progressive impairment of cardiac contractility.  51:A553-A553. 2002

A genome-wide scan for loci linked to plasma levels of glucose and HbA 1c in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study.  51:833-840. 2002

Longitudinal Study on Pubertal Insulin Resistance.  50:2444-2450. 2001

Effects of Insulin Resistance and type 2 diabetes on the nuclear magnetic resonance lipoprotein subclass profile.  50:A147-A147. 2001

Effects of race on the NMR lipoprotein profile and insulin resistance syndrome: Lipids and blood pressure are not influenced by insulin resistance in African Americans.  50:A306-A306. 2001

Postprandial glucose and insulin responses to dextrin-containing medical nutritional bars in persons with type 2 diabetes mellitus.  50:A366-A366. 2001

SNARE proteins (Syntaxin4, VAMP2, munc18) and skeletal muscle insulin resistance in rats and humans.  50:A270-A270. 2001

Erratum: Visceral fat, insulin sensitivity and upids in prepulbertal childre. (Diabetes 48: 1515-1521, 1999).  50:477. 2001

Visceral fat, insulin sensitivity, and lipids in prepubertal children. (vol 48, pg 1515, 1999).  50:477-477. 2001

Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors.  50:515-520. 2001

Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.  50:2641-2645. 2001

Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes.  50:1227-1236. 2001

Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis: Role of GSK3β.  50:1171-1179. 2001

Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile in the DCCT/EDIC cohort: Associations with retinopathy and nephropathy.  49:A269-A269. 2000

Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile in the DCCT/EDIC cohort: Effects of gender, HbAlc, and DCCT randomization group..  49:A267-A267. 2000

Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile: Effects of hyperglycemia, lipoprotein glycation, and comparison with standard lipid profile.  49:A268-A268. 2000

Paraoxonase genotype (192 Gln-Arg) and serum paraoxonase-arylesterase activity: Relationship with Type 1 diabetes and nephropathy.  49:A157-A157. 2000

Troglitazone is an effective therapeutic agent in patients with steroid-induced diabetes.  49:A129-A129. 2000

Cloning of a T-type Ca ²⁺ channel isoform in insulin-secreting cells.  49:59-64. 2000

Visceral fat, insulin sensitivity, and lipids in prepubertal children.  48:1515-1521. 1999

Hyperfibrinogenemia is associated with nephropathy in type 1 diabetes.  48:A139-A139. 1999

Low birth weight is associated with reduced expression of GLUT4 and carnitine palmitoyltransferase-1 in adult skeletal muscle.  48:A274-A275. 1999

Plasminogen activator inhibitor-1 is increased in type 1 diabetes patients with hypertension.  48:A43-A43. 1999

Toward rational diagnostic criteria for the insulin resistance syndrome.  48:A29-A29. 1999

Troglitazone prevents glucocorticoid-induced insulin resistance in humans.  48:A75-A75. 1999

Apolipoprotein CIII polymorphism confers altered chemical composition of triglyceride-rich lipoprotein in type 1 diabetes.  47:A32-A32. 1998

Insulin resistance and defective glucose-insulin coupling in ketosis-prone type 2 diabetes of African-American youth.  47:A306-A306. 1998

The role of uncoupling proteins in metabolic fuel partitioning and human obesity.  47:A13-A13. 1998

Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African- American subjects.  47:685-687. 1998

Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in 1 diabetes mellitus.  47:1472-1479. 1998

Expression of mRNAs encoding uncoupling proteins in human skeletal muscle. Effects of obesity and diabetes.  47:1935-1940. 1998

Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.  47:1920-1927. 1998

Decreased insulin-stimulated Z-deoxyglucose uptake and impaired GLUT4 translocation in skeletal muscle of transgenic mice overexpressing glutamine: Fructose-6-phosphate amidotransferase..  46:259-259. 1997

Ketosis-prone NIDDM in African-American children..  46:262-262. 1997

NIDDM and obesity are associated with Protein Kinase C abnormalities in human skeletal muscle.  46:87-87. 1997

Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study..  46:63-69. 1997

Muscle rad expression and human metabolism: Potential role of the novel ras-related GTPase in energy expenditure and body composition.  46:444-450. 1997

Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study..  45:742-748. 1996

Correlation of leptin and body fat in obese, lean, and lipodystrophic humans..  45:1229-1229. 1996

Dual energy X-ray absorptiometry (DXA) assessment of fat mass and distribution and its association with the insulin resistance syndrome (IRS)..  45:387-387. 1996

Fat and muscle tissue express a common abnormality in translocation/trafficking of GLUT4/vp165 containing vesicles in NIDDM..  45:573-573. 1996

The metabolic significance of leptin in humans..  45:940-940. 1996

Epidermal growth factor induces glucose storage in transgenic 3T3-L1 adipocytes overexpressing epidermal growth factor receptors.  45:1619-1625. 1996

ABNORMALITIES IN GLUT-4 TRANSLOCATION AND TRAFFICKING IN SKELETAL-MUSCLE CAUSE INSULIN-RESISTANCE IN HUMANS.  44:A164-A164. 1995

GLUCOSAMINE (GLMN) INDUCES INSULIN-RESISTANCE (IR) IN-VIVO BY AFFECTING GLUT 4 TRANSLOCATION IN SKELETAL-MUSCLE - IMPLICATIONS FOR GLUCOSE TOXICITY.  44:A15-A15. 1995

RAD EXPRESSION IN SKELETAL-MUSCLE OF TYPE-II DIABETICS.  44:A186-A186. 1995

MUSCLE GLUT 4 EXPRESSION IS A FAMILIAL TRAIT AND DETERMINES INSULIN SENSITIVITY IN HUMANS INDEPENDENT OF OBESITY.  43:A69-A69. 1994

THE GOLGI-APPARATUS IS NOT REQUIRED FOR INSULIN STIMULATION OF GLUCOSE-TRANSPORT AND GLUT-4 TRANSLOCATION IN RAT ADIPOCYTES.  43:A119-A119. 1994

Biological actions of insulin are differentially regulated by glucose and insulin in primary cultured adipocytes: Chronic ability to increase glycogen synthase activity.  43:53-62. 1994

Saturated fatty acid-induced insulin resistance in rat adipocytes.  43:540-545. 1994

Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters.  42:1773-1785. 1993

MECHANISMS UNDERLYING PERIPHERAL-NERVE GLUCOSE-UPTAKE SUPPRESSION IN DIABETES.  42:A102-A102. 1993

Amplification of insulin secretion by lipid messengers.  42:367-374. 1993

Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes: Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters.  42:1773-1785. 1993

Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.  41:465-475. 1992

Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes: Effects on glucose transporter gene expression.  41:274-285. 1992

Production of marked prolongation of islet xenograft survival (rat to mouse) by local release of mouse and rat antilymphocyte sera at transplant site.  40:482-485. 1991

Renal adaptation to dietary phosphate restriction in rats: Interactions with insulin and calcitriol.  40:1134-1140. 1991

Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.  37:590-599. 1988

Interferon-mediated induction of Ia antigen expression on isolated murine whole islets and dispersed islet cells.  35:1174-1177. 1986

The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts.  35:83-88. 1986

Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications.  35:916-921. 1986

Insulin induces progressive insulin resistance in cultured rat adipocytes: Sequential effects at receptor and multiple postreceptor sites.  35:258-267. 1986

Factors related to learning and behavior in diabetics 1985

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.  34:222-234. 1985

Comparison of monitoring blood vs. urine glucose in obese type II diabetics 1983

Evidence for genetic admixture as a determinant in the occurrence of insulin-dependent diabetes mellitus in U.S. blacks.  31:532-537. 1982

Concordance and discrepancy in perceptions of diabetic adolescents' social behaviors: mother, father, child 1982

HLA-A, -B, and -DR associations in type I diabetes mellitus with onset after age forty.  31:122-125. 1982

Stimulation of microvascular cyclic-AMP phosphodiesterase activity by insulin, spermine and concanavalin.  31. 1982

Perceived needs of diabetes patient educators 1980

Metabolic effects of glucose insulin potassium (GIK) infusion during acute myocardial infarction (AMI).  26. 1977

Insulin secretion in protein-calorie malnutrition. I. Quantitative abnormalities and response to treatment..  20:542-551. 1971

Biochemistry of extrapancreatic tumor hypoglycemia..  19:248-258. 1970

Hyperglycemic, hyperosmolar, nonketoacidotic diabetes. A complication of steroid and immunosupressive therapy..  18:107-110. 1969